BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29719272)

  • 1. Serum lipidomic analysis for the discovery of biomarkers for major depressive disorder in drug-free patients.
    Kim EY; Lee JW; Lee MY; Kim SH; Mok HJ; Ha K; Ahn YM; Kim KP
    Psychiatry Res; 2018 Jul; 265():174-182. PubMed ID: 29719272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipidomics reveals potential lipid markers of major depressive disorder.
    Liu X; Li J; Zheng P; Zhao X; Zhou C; Hu C; Hou X; Wang H; Xie P; Xu G
    Anal Bioanal Chem; 2016 Sep; 408(23):6497-507. PubMed ID: 27457104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
    Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
    J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of serum protein biomarkers in drug-free patients with major depressive disorder.
    Lee MY; Kim EY; Kim SH; Cho KC; Ha K; Kim KP; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():60-8. PubMed ID: 27105922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of major depressive disorder by combining multimodal information from heart rate dynamics and serum proteomics using machine-learning algorithm.
    Kim EY; Lee MY; Kim SH; Ha K; Kim KP; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jun; 76():65-71. PubMed ID: 28223106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum proteomic profiling of major depressive disorder.
    Bot M; Chan MK; Jansen R; Lamers F; Vogelzangs N; Steiner J; Leweke FM; Rothermundt M; Cooper J; Bahn S; Penninx BW
    Transl Psychiatry; 2015 Jul; 5(7):e599. PubMed ID: 26171980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study.
    Kuwano N; Kato TA; Setoyama D; Sato-Kasai M; Shimokawa N; Hayakawa K; Ohgidani M; Sagata N; Kubo H; Kishimoto J; Kang D; Kanba S
    J Affect Disord; 2018 Apr; 231():74-82. PubMed ID: 29454180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipids, recent suicide attempt and recent suicide status in patients with major depressive disorder.
    Baek JH; Kang ES; Fava M; Mischoulon D; Nierenberg AA; Yu BH; Lee D; Jeon HJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():113-8. PubMed ID: 24495778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
    Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
    J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Plasma Lipidomic Profiles in Adult Patients with Schizophrenia and Major Depressive Disorder.
    Wang F; Guo L; Zhang T; Cui Z; Wang J; Zhang C; Xue F; Zhou C; Li B; Tan Q; Peng Z
    Medicina (Kaunas); 2022 Oct; 58(11):. PubMed ID: 36363466
    [No Abstract]   [Full Text] [Related]  

  • 11. Elevated triglyceride levels are associated with cognitive impairments among patients with major depressive disorder.
    Shao TN; Yin GZ; Yin XL; Wu JQ; Du XD; Zhu HL; Liu JH; Wang XQ; Xu DW; Tang WJ; Hui L
    Compr Psychiatry; 2017 May; 75():103-109. PubMed ID: 28342378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voxel-based morphometry study of the insular cortex in female patients with current and remitted depression.
    Liu CH; Jing B; Ma X; Xu PF; Zhang Y; Li F; Wang YP; Tang LR; Wang YJ; Li HY; Wang CY
    Neuroscience; 2014 Mar; 262():190-9. PubMed ID: 24406440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
    Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
    Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis.
    Ding X; Yang S; Li W; Liu Y; Li Z; Zhang Y; Li L; Liu S
    PLoS One; 2014; 9(5):e97479. PubMed ID: 24870353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipidomic analysis of serum samples from migraine patients.
    Ren C; Liu J; Zhou J; Liang H; Wang Y; Sun Y; Ma B; Yin Y
    Lipids Health Dis; 2018 Feb; 17(1):22. PubMed ID: 29394939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS-Based Lipidomic Analysis of Serum Samples from Spontaneously Hypertensive Rats Treated with an Extract of
    Lee DY; Choi BR; Yoon D; Kim HG; Lee MH; Kim GS; Lee YS
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32708994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between serum lipids and major depressive disorder: results from the Netherlands Study of Depression and Anxiety (NESDA).
    van Reedt Dortland AK; Giltay EJ; van Veen T; van Pelt J; Zitman FG; Penninx BW
    J Clin Psychiatry; 2010 Jun; 71(6):729-36. PubMed ID: 20021996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
    Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
    Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying current and remitted major depressive disorder with the Hurst exponent: a comparative study on two automated anatomical labeling atlases.
    Jing B; Long Z; Liu H; Yan H; Dong J; Mo X; Li D; Liu C; Li H
    Oncotarget; 2017 Oct; 8(52):90452-90464. PubMed ID: 29163844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma metabolome analysis of patients with major depressive disorder.
    Kawamura N; Shinoda K; Sato H; Sasaki K; Suzuki M; Yamaki K; Fujimori T; Yamamoto H; Osei-Hyiaman D; Ohashi Y
    Psychiatry Clin Neurosci; 2018 May; 72(5):349-361. PubMed ID: 29356314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.